Abstract:OBJECTIVE:To investigate the incidences of urea cycle defects (UCDs) in the patients with hyperammonemia and study their etiology, clinical and laboratory features.METHODS:In the past 7 years, 26 cases (10.2%) of UCDs were detected from 254 patients with hyperammonemia. The etiological diagnoses were made by blood amino acids analysis, urinary organic acid analysis and blood acylcarnitine profile analysis. Three patients with citrullinemia type II were further confirmed by liver pathological analysis and gene diagnosis.RESULTS:Among 26 cases with UCDs, 15 had ornithine transcarbamylase (OTC) deficiency, 5 had citrullinemia type I, 3 had citrullinemia type II and 3 patients had arginemia. The age of onset of the patients ranged from 3 days to 13 years. Three cases (11.5%) developed hyperammonemic encephalopathy during neonatal period. Thirteen (50.0%), 7 (26.9%) and 3 (11.5%) cases developed clinical symptoms at the age of 1 to 12 months, 1 to 3 years and 6 to 13 years, respectively. Positive family history was found in 11 cases (42.3%). Among 26 patients with UCDs, 9 (34.6%) were hospitalized with the complains of seizures, psychomotor retardation, vomiting and unconsciousness, 8 (30.8%) with recurrent vomiting, headache and coma, 6 due to liver dysfunction. Intrahepatic cholestatic jaundice was found in 3 patients with citrullinemia type II. Blood ammonia ranged from 58 to 259 micromol/L on their first visit to our hospital. Twenty cases (76.9%) had liver dysfunction, 4 patients (15.4%) were diagnosed postmortem. Twenty-one patients got treatment and were followed up. Among them, 7 cases died of hyperammonemic encephalopathy or upper alimentary tract bleeding. Clinical improvement was observed in 14 cases. A boy with OTC deficiency who received a partial liver transplant from his mother showed normal general condition for two years.CONCLUSIONS:UCDs are the most frequent causes of congenital hyperammonemia. In this study, 26 patients (10.2%) with UCDs were identified from 254 patients with hyperammonemia resulting in encephalopathy and liver dysfunction. Early diagnosis and treatment can contribute a lot to improve the prognosis of the patients. Blood ammonia assay and further etiological analysis should be considered in the differential diagnosis of neurological and hepatic abnormality.

Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan

Long‐term outcome of urea cycle disorders: Report from a nationwide study in Japan

Urea cycle disorders and indications for liver transplantation

Choosing between medical management and liver transplant in urea cycle disorders: A conceptual framework for parental treatment decision‐making in rare disease

Liver Transplantation in Children with Urea Cycle Disorders: The Importance of Minimizing Waiting Time

Hyperammonemia in a carbamoyl-phosphate synthetase 1 deficiency recipient after living-donor liver transplantation from a carrier donor: a case report

Severity-adjusted evaluation of initial dialysis on short-term health outcomes in urea cycle disorders

Expression and function of the urea cycle in widely‐used hepatic cellular models

Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium

Fifteen years of urea cycle disorders brain research: Looking back, looking forward

[Clinical and Laboratory Screening Studies on Urea Cycle Defects].

Clinical findings of patients with hyperammonemia affected by urea cycle disorders with hepatic encephalopathy

Current status and future directions of liver transplantation for metabolic liver disease in children

Clinical and Laboratory Study on Late-Onset Urea Cycle Defects

Living Donor Liver Transplantation for Noncirrhotic Inheritable Metabolic Liver Diseases: Impact of the Use of Heterozygous Donors

Impact of citrulline substitution on clinical outcome after liver transplantation in carbamoyl phosphate synthetase 1 and ornithine transcarbamylase deficiency

Modified by the Innovative Drugs and Strategies—Pattern of Selected Indications for Pediatric Liver Transplantation

[Inherited Metabolic Diseases and Liver Transplantation].

A successful liver transplantation in a patient with neonatal-onset carbamoyl phosphate synthetase-1 deficiency

Acute liver failure due to DGUOK deficiency-is liver transplantation justified?

Liver Transplantation Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Atypical Mevalonic Aciduria